CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Timmermann, S.
Right arrow Articles by Munger, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timmermann, S.
Right arrow Articles by Munger, K.

Cell Growth & Differentiation, Vol 8, Issue 4 361-370, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines

S Timmermann, PW Hinds and K Munger
Pathology Department, Harvard Medical School, Boston, Massachusetts 02115-5701, USA.

We have investigated the functional integrity of the retinoblastoma tumor suppressor pathway in five human squamous cell carcinoma lines. Elevated activity of cyclin-dependent kinase 6 (cdk6), a pRB kinase, was detected in all five squamous cell carcinoma lines. Overexpression of the cdk6 protein was detected in one of the five cell lines. The cdk6-specific inhibitor p18ink4C is expressed and associated with cdk6 in all five squamous cell carcinoma lines. In contrast, only very low levels of p16ink4A were detected in these cell lines. This may contribute to the elevated activity of cdk6 in these lines. Elevated activity of cdk6 may result in hyperphosphorylation of the retinoblastoma protein and, therefore, compromise its negative growth-regulatory activity.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. M. Ayala, T. Misteli, and F. E. Baralle
TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression
PNAS, March 11, 2008; 105(10): 3785 - 3789.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
S. Choi and J.N. Myers
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
J. Dent. Res., January 1, 2008; 87(1): 14 - 32.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Takaki, K. Fukasawa, I. Suzuki-Takahashi, K. Semba, M. Kitagawa, Y. Taya, and H. Hirai
Preferences for Phosphorylation Sites in the Retinoblastoma Protein of D-Type Cyclin-Dependent Kinases, Cdk4 and Cdk6, In Vitro
J. Biochem., March 1, 2005; 137(3): 381 - 386.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. J. Lucas, J. Domenico, and E. W. Gelfand
Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells
Mol. Cancer Res., February 1, 2004; 2(2): 105 - 114.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. K. Ericson, D. Krull, P. Slomiany, and M. J. Grossel
Expression of Cyclin-Dependent Kinase 6, but not Cyclin-Dependent Kinase 4, Alters Morphology of Cultured Mouse Astrocytes
Mol. Cancer Res., July 1, 2003; 1(9): 654 - 664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-o. Piboonniyom, S. Duensing, N. W. Swilling, J. Hasskarl, P. W. Hinds, and K. Munger
Abrogation of the Retinoblastoma Tumor Suppressor Checkpoint During Keratinocyte Immortalization Is Not Sufficient for Induction of Centrosome-mediated Genomic Instability
Cancer Res., January 15, 2003; 63(2): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. C. Coleman, Z. A. Stewart, T. A. Day, J. L. Netterville, B. B. Burkey, and J. A. Pietenpol
Analysis of Cell-Cycle Checkpoint Pathways in Head and Neck Cancer Cell Lines: Implications for Therapeutic Strategies
Arch Otolaryngol Head Neck Surg, February 1, 2002; 128(2): 167 - 176.
[Abstract] [Full Text] [PDF]


Home page
Crit. Rev. Oral Biol. Med.Home page
R. Todd, P.W. Hinds, K. Munger, A.K. Rustgi, O.G. Opitz, Y. Suliman, and D.T. Wong
CELL CYCLE DYSREGULATION IN ORAL CANCER
Crit. Rev. Oral. Biol. Med., January 1, 2002; 13(1): 51 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Grossel, G. L. Baker, and P. W. Hinds
cdk6 Can Shorten G1 Phase Dependent upon the N-terminal INK4 Interaction Domain
J. Biol. Chem., October 15, 1999; 274(42): 29960 - 29967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Cover, S. J. Hsieh, S. H. Tran, G. Hallden, G. S. Kim, L. F. Bjeldanes, and G. L. Firestone
Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling
J. Biol. Chem., February 13, 1998; 273(7): 3838 - 3847.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-X. Yan, H. Nakagawa, M.-H. Lee, and A. K. Rustgi
Transforming Growth Factor-alpha Enhances Cyclin D1 Transcription through the Binding of Early Growth Response Protein to a cis-Regulatory Element in the Cyclin D1 Promoter
J. Biol. Chem., December 26, 1997; 272(52): 33181 - 33190.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.